M. Kotyleva

The use of E. faecium probiotic and autoprobiotic in patients with type 2 diabetes mellitus

N. V. Bakulina, V. Simanenkov, S. Tikhonov, 2022, HERALD of North-Western State Medical University named after I.I. Mechnikov.

GASTROINTESTINAL DYSFUNCTIONS AND PERIPHERAL INFLAMMATORY CYTOKINES IN PARKINSON’S DISEASES

I. Miliukhina, A. Suvorov, E. Ermolenko, 2019 .

Profile of subpopulation composition of regulatory T lymphocytes and intestinal microbiota in patients with irritable bowel syndrome

I. Shumikhina, M. Serebryakova, I. Kudryavtsev, 2020, Medical Immunology (Russia).

Consortium of Indigenous Fecal Bacteria in the Treatment of Metabolic Syndrome

A. Karaseva, E. Ermolenko, A. Shishkin, 2022, Microorganisms.

Intestinal microbiota, gastroenterological complaints and quality of life in overweight, obese and type 2 diabetes patients

N. V. Bakulina, V. Simanenkov, S. Tikhonov, 2022, Profilakticheskaya meditsina.

Autoprobiotics as an Approach for Restoration of Personalised Microbiota

A. Lapidus, A. Korobeynikov, I. Kudryavtsev, 2018, Front. Microbiol..

Use of autoprobiotics in the complex therapy of axial spondyloarthritis

A. Maslyansky, I. Gaydukova, A. Suvorov, 2023, Russian Journal for Personalized Medicine.

Effects of Indigenous Enterococci on the Intestinal Microbiota and the Behavior of Rats on Correction of Experimental Dysbiosis

I. Abdurasulova, A. Karaseva, V. Sizov, 2018, Neuroscience and Behavioral Physiology.